Every week, Buffett Radar scores every stock in the S&P 500 against Warren Buffett's six core investment criteria: proven track record, durable profit margins, low debt, high return on equity, attractive valuation, and strong free cash flow. Most stocks fail. At any given time, fewer than 8% of the index achieves "High Alignment" status across all six.
But that failure is not distributed evenly. Some sectors consistently cluster near the top of our scoring system, with multiple companies passing five or even all six criteria. Other sectors almost never produce a single qualifying name. This pattern is not random — it reflects structural differences in how industries generate returns, deploy capital, and are valued by the market.
We analyzed the distribution of Buffett-criteria scores across all eleven GICS sectors over the first quarter of 2026. The results reveal five sectors where value is quietly concentrating — and two where it remains conspicuously absent.
Sector 1 of 5
Healthcare has become the single richest hunting ground for Buffett-style value in the current market. The reason is straightforward: the sector is experiencing a wave of patent expirations on blockbuster drugs, and investors are pricing in worst-case revenue declines across the board. But the companies most affected by these patent cliffs are not startups with a single product — they are diversified pharmaceutical giants with decades of operating history, deep pipelines, and enormous cash generation.
Consider the profile of a typical large-cap pharma company right now. Many have 50+ years of continuous operations, satisfying the track record criterion easily. Their gross margins have remained in the 65-75% range for years, reflecting genuine pricing power from patent-protected products and established distribution. Debt-to-equity ratios, which spiked during the acquisition wave of 2019-2021, have been steadily brought down as companies used their prodigious free cash flow to deleverage. Return on equity for the top names sits comfortably above 20%.
And here is where it gets interesting for value investors: because the market is fixated on what happens when a key drug loses exclusivity, the price-to-earnings ratios on many of these companies have compressed to levels not seen since the early pandemic period. We are seeing established pharma names trading at 10-12x forward earnings while generating FCF yields north of 8%. Companies with the profile of a Johnson & Johnson, Pfizer, or AbbVie — decades-old businesses with fortress balance sheets — are being valued as if their entire revenue base is at risk, when in reality the exposed portion is often 15-25% of total sales.
The main barrier for some healthcare names is debt from recent acquisitions. As paydown continues through 2026, we expect the number of fully qualifying healthcare stocks to increase. Any further P/E compression from patent-cliff fears would widen the opportunity further.
Sector 2 of 5
The energy sector tells one of the most misunderstood stories in the current market. After the commodity price boom of 2022-2023, oil and gas stocks experienced a sharp re-rating upward, briefly becoming Wall Street darlings. Then came the inevitable pullback as crude prices normalized, and with it came a narrative that energy was "over." Investors rotated aggressively into AI-adjacent technology. Energy was left behind.
But the integrated majors — the ExxonMobils, Chevrons, and Shells of the index — did something unusual during the boom years: they showed discipline. Instead of repeating the mistakes of previous cycles by ramping capital expenditure and taking on debt to chase production growth, they paid down billions in obligations, bought back shares, and built cash reserves. The result is that the largest energy companies now have the cleanest balance sheets they have had in over a decade.
Debt-to-equity ratios for the integrated majors have fallen below 0.3 in several cases — levels that would have been unthinkable five years ago. Return on equity, even with normalized commodity prices, remains solidly above 15% because these companies are operating far more efficiently than in any prior cycle. Free cash flow generation remains robust because capital discipline has kept spending in check.
Buffett himself validated this thesis when Berkshire Hathaway built its massive position in Occidental Petroleum. He saw what the numbers showed: a company with decades of operating history, improving margins, falling debt, high returns on equity, a low price-to-earnings ratio, and strong cash flow. It passed all six criteria.
"I'm not predicting oil prices. I'm saying that at today's prices, these businesses generate very good returns on the capital employed, and they're available at sensible prices." — Warren Buffett, 2023 Annual Meeting
The primary risk factor is margin cyclicality. If commodity prices decline significantly, margins and ROE would compress. But at current levels, several integrated majors already qualify. Continued capital discipline and further debt reduction would strengthen the case for mid-cap energy names that are close to qualifying.
Sector 3 of 5
Consumer staples is the sector most associated with Warren Buffett's investment philosophy. Coca-Cola, Procter & Gamble, Kraft Heinz — these are the kinds of businesses Buffett has owned for decades. The reason is structural: consumer staples companies sell products that people buy regardless of economic conditions. Toothpaste, laundry detergent, breakfast cereal, and soft drinks are purchased in recessions and expansions alike. This creates the kind of revenue stability that translates directly into consistent margins, predictable cash flows, and durable returns on equity.
In 2026, consumer staples have become remarkably cheap by historical standards. The sector has been out of favor for three years running as investors have chased the AI and technology rally. Fund flows data shows sustained outflows from staples ETFs and into technology-focused vehicles. The result is that many blue-chip consumer companies now trade at their lowest valuations relative to the broader S&P 500 in over a decade.
This is precisely the kind of dislocation that Buffett's criteria are designed to capture. When a high-quality business becomes cheap not because of deteriorating fundamentals but because of shifting market sentiment, the scoring system lights up. The businesses themselves have not changed — margins are stable, debt is low, ROE is consistent, and cash flow keeps compounding. What has changed is the price investors are willing to pay.
The main limiting factor is debt for companies that made large acquisitions in the past five years. Those that have been deleveraging are approaching the threshold. Further P/E compression or continued debt paydown would push several more names into full qualification. Any rotation out of growth and into defensive names would likely happen quickly once it starts.
Sector 4 of 5
The regional banking sector offers perhaps the most compelling case of value created by a specific, identifiable event whose effects have long since dissipated in reality but persist stubbornly in market pricing. The regional banking crisis of March 2023 — triggered by the failures of Silicon Valley Bank and Signature Bank — caused a sector-wide sell-off that punished well-managed community and regional banks alongside the handful that had made reckless duration bets.
Nearly three years later, the fundamental picture for most regional banks has transformed. Regulators imposed stricter liquidity requirements. Banks proactively restructured their bond portfolios, realizing losses but emerging with far less interest rate risk. Deposit bases have stabilized. Loan quality has held up remarkably well despite fears of a commercial real estate crash that, for most regions, did not materialize at catastrophic levels.
The result is a cohort of regional banks that now have fortress balance sheets — high capital ratios, conservative loan-to-deposit ratios, and clean credit portfolios — but continue to trade at significant discounts to tangible book value. Many trade at 0.7-0.9x book, implying the market believes they are worth less than the liquidation value of their assets. Meanwhile, these same banks are generating ROEs of 12-18% and paying dividend yields of 3-5%.
Buffett has a long history of investing in well-managed banks at attractive valuations. His positions in Wells Fargo, US Bancorp, and Bank of America were all initiated during periods of banking sector pessimism. The current regional bank landscape mirrors those conditions: fundamentally sound institutions being tarred with a crisis-era brush.
The key catalyst would be a sustained period without negative banking headlines. Each quarter of clean earnings reports incrementally rebuilds confidence. Additionally, any Fed rate cuts that steepen the yield curve would boost net interest margins, improving both the margin and ROE criteria simultaneously.
Sector 5 of 5
The industrials sector is the sleeper on this list. It does not carry the dramatic narrative of patent cliffs or banking crises. Instead, it contains a large number of companies with quietly exceptional business characteristics: long operating histories, durable competitive advantages in niche markets, consistent margins, and strong cash generation. Many of these companies are not household names, but they dominate their specific markets in ways that create exactly the kind of moat Buffett prizes.
Think of companies that make critical industrial components — electrical connectors, water treatment systems, aerospace fasteners, railroad equipment. These are not glamorous businesses, but they share common traits: high switching costs for their customers, decades of operational expertise, and end markets that grow steadily without the boom-bust cycles of technology or commodities. When a manufacturer has been making a critical component for 40 years and has qualified supplier relationships with every major customer in the industry, that is a moat.
The current opportunity in industrials is more nuanced than in other sectors. These companies generally pass five of six Buffett criteria with ease — track record, margins, debt, ROE, and cash flow are typically strong. The criterion they most often fail on is valuation. Quality industrials have historically commanded premium multiples, and the market has not discounted them as aggressively as it has healthcare or energy.
However, a subset of industrial companies has seen P/E compression due to concerns about a manufacturing slowdown and inventory destocking cycles. These pockets of weakness are pushing some names across the valuation threshold, creating opportunities where all six criteria align.
Any broader market correction that compresses industrial P/E ratios toward historical averages would unlock a large number of qualifying names. Additionally, companies experiencing temporary earnings dips from inventory cycles may see their P/E ratios spike briefly before normalizing — creating windows where the valuation criterion fails even though the underlying business remains strong. Patience is required here.
Not every sector rewards the Buffett-criteria approach. Two sectors consistently score poorly across our system, and understanding why is as instructive as understanding where value concentrates.
Technology companies dominate the S&P 500 by market weight, and many of them are extraordinary businesses by any operational measure. They have high margins, strong ROE, massive free cash flow, and in many cases decades of operating history. The issue is criterion 5: valuation. The AI-driven rally that began in late 2022 and has continued through 2026 has pushed price-to-earnings ratios on major technology stocks to levels that are 40-80% above their 5-year averages and well above sector peers. When a company trades at 35x earnings with a historical average of 22x, the valuation criterion fails regardless of how excellent the underlying business is. Technology stocks frequently pass five of six criteria but stumble on the one that determines whether you are paying a reasonable price. Until valuations normalize — either through price declines or earnings growth catching up — the sector will remain underrepresented in our High Alignment tier.
Real estate investment trusts (REITs) and real estate operating companies face a structural challenge with Buffett's criteria: they are inherently debt-heavy. The REIT business model relies on leverage to acquire and develop properties, and debt-to-equity ratios above 1.0 are common. This means the low-debt criterion fails for the vast majority of the sector. Additionally, the post-pandemic repricing of office and certain commercial real estate assets has compressed margins and ROE for many names. While pockets of value exist in specific REIT sub-sectors, the structural leverage issue means real estate rarely produces qualifying names under a Buffett-style framework.
The common thread across all five sectors is a divergence between business quality and market price. In each case, the companies themselves are performing well on the operational metrics Buffett cares about — margins, returns on equity, debt levels, and cash generation. What has changed is the price the market assigns to those cash flows, driven by sector-specific fears or broader rotations in investor sentiment. That divergence is where value investing works, and it is precisely what a systematic, criteria-based approach is designed to detect.
If you want to see which specific S&P 500 stocks are currently scoring highest across these sectors, our free weekly watchlist highlights the names approaching High Alignment, and Pro subscribers receive real-time alerts when a stock crosses the threshold.
Disclaimer: This article is for informational and educational purposes only. It does not constitute financial advice, and no specific stocks are being recommended for purchase or sale. Sector-level observations reflect general patterns in our scoring system and should not be interpreted as predictions of future performance. Always conduct your own research and consult a qualified financial advisor before making investment decisions. Read our full disclaimer.
